A new aristolactam alkaloid and anti-platelet aggregation constituents from Piper taiwanense

Planta Med. 2004 Feb;70(2):174-7. doi: 10.1055/s-2004-815497.

Abstract

A new alkaloid, piperolactam E, and fourteen known compounds have been isolated from the stem of Piper taiwanense. Bioassay-guided fractionation of the methanolic extract led to the isolation, from the chloroform-soluble part, of 4-allylcatechol, eugenol, trans-caffeic aldehyde, 2-hydroxy-1-methoxy-4 H-dibenzo[ de,g]quinoline-4,5-(6 H)-dione, piperolactam B, piperolactam C, and piperolactam E as the active principles of anti-platelet aggregation in vitro. The derived 1,2-diacetoxy-4-allyl-benzene and eugenol acetate exhibit stronger anti-platelet aggregation activities induced by arachidonic acid than 4-allylcatechol and eugenol, respectively.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / administration & dosage
  • Alkaloids / pharmacology
  • Alkaloids / therapeutic use
  • Animals
  • Aristolochic Acids / chemistry
  • Dose-Response Relationship, Drug
  • Inhibitory Concentration 50
  • Phytotherapy*
  • Piper*
  • Plant Extracts / administration & dosage
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Plant Stems
  • Platelet Aggregation / drug effects*
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / pharmacology*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Rabbits

Substances

  • Alkaloids
  • Aristolochic Acids
  • Plant Extracts
  • Platelet Aggregation Inhibitors